Business Wire6d
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced detailed final overall survival (OS) results from CONTACT-02, a phase 3 pivotal study evaluating cabozantinib (CABOMETYX ...
Palo Alto Weekly4d
City’s new shuttle service is a departure from the past
Though the new shuttles will be emblazoned with the city logo, they will be operated by Via, a transportation company that currently ... such as Google and Genentech. Some will be hybrids, others ...
STAT5d
Genentech, a biotech with a storied past, confronts new turbulence in the present
For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...
CEO exits from company with 2nd-largest biotech IPO this year
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
STAT5d
The essential biotech updates of the day
AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...
The Verge on MSN3d
PayPal has a new logo that makes it look just like everything else
The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations ...
89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer
SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the ...
Newsday2d
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
NEW YORK — All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest ...
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
Mr. Mullins added, “I am thrilled to join Tempest at such an exciting time as the team prepares to advance amezalpat into a pivotal study. Amezalpat has demonstrated very strong results in the ...
Le Lézard3d
Implantica conducts first national RefluxStoptm User meeting with 21 participating surgeons, 1.5 years after launch in Italy
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, had the pleasure to host a regional full day User meeting with 21 surgeons attending last ...